Get started
Design Therapeutics, Inc.Design Therapeutics, Inc.Design Therapeutics, Inc.

Design Therapeutics, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

DSGN trade ideas

$DSGN is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea Design Therapeutics is a biotechnology company developing a platform of gene targeted chimera (GeneTAC™) small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions. The share price is rising and gonna continue this trend today. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price today. So I opened a long position from $29,32; stop-loss — $19, 40 ; take-profit — 23,49/MOC price. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas.
NASDAQ:DSGNLong
by KozakHlib